Literature DB >> 2763992

Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study.

N D Wong1, L A Cupples, A M Ostfeld, D Levy, W B Kannel.   

Abstract

The role of standard coronary heart disease risk factors in predicting the long-term risk of recurrent coronary events in survivors of myocardial infarction is examined. Of 697 subjects (464 males and 233 females) who experienced an initial myocardial infarction during 30 years of follow-up in the Framingham Study, 459 returned for a baseline examination and were followed for up to 32 years (mean = 9.7 years) for incident reinfarction or coronary death. The Cox proportional hazards model was used to evaluate the relation of postinfarction risk factors with reinfarction and coronary death. Age-adjusted analyses showed the risk of reinfarction to be positively associated with blood pressure and serum cholesterol. Risk of coronary death was strongly associated with blood sugar level, systolic blood pressure, serum cholesterol, heart rate, diabetes, and interim reinfarction. In multivariable analyses, systolic pressure, serum cholesterol, and diabetes were predictive of reinfarction; relative weight was inversely associated with reinfarction. Systolic pressure, serum cholesterol, and the prevalence of diabetes persisted as independent predictors of coronary death. When adjustments were made for the effects of these variables, women were at only half the risk of coronary death compared with men. Higher baseline risk factors in women compared with men may obscure an important survival advantage in women. In persons recovered from an initial myocardial infarction, standard risk factors, particularly systolic pressure, serum cholesterol, and diabetes, remain important determinants of coronary prognosis over many years and warrant attention in preventing subsequent events.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2763992     DOI: 10.1093/oxfordjournals.aje.a115360

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

1.  Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic.

Authors:  Frank L Meyskens; Gregory A Curt; Dean E Brenner; Gary Gordon; Ronald B Herberman; Olivera Finn; Gary J Kelloff; Samir N Khleif; Caroline C Sigman; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

2.  Role of age and sex in short-term and long term mortality after a first Q wave myocardial infarction.

Authors:  J Marrugat; M Gil; R Masiá; J Sala; R Elosua; J M Antó
Journal:  J Epidemiol Community Health       Date:  2001-07       Impact factor: 3.710

3.  Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up.

Authors:  R B Singh; S S Rastogi; R Verma; B Laxmi; R Singh; S Ghosh; M A Niaz
Journal:  BMJ       Date:  1992-04-18

Review 4.  The role of models within economic analysis: focus on type 2 diabetes mellitus.

Authors:  Douglas Coyle; Karen M Lee; Bernie J O'Brien
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  Ten year mortality in patients with suspected acute myocardial infarction.

Authors:  J Launbjerg; P Fruergaard; J K Madsen; L S Mortensen; J F Hansen
Journal:  BMJ       Date:  1994-05-07

Review 6.  Social support and prognosis following first myocardial infarction.

Authors:  H C Bucher
Journal:  J Gen Intern Med       Date:  1994-07       Impact factor: 5.128

Review 7.  Clinical modifiers for heart failure following myocardial infarction.

Authors:  Nandan S Anavekar; Nagesh S Anavekar
Journal:  Curr Heart Fail Rep       Date:  2005-12

8.  Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease.

Authors:  M Ishihara; H Sato; T Kawagoe; Y Shimatani; S Kurisu; K Nishioka; Y Kouno; T Umemura; S Nakamura
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

Review 9.  Diagnosis of CAD in patients with diabetes: who to evaluate.

Authors:  Lawrence H Young; Powell Jose; Deborah Chyun
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

10.  Cardiovascular risk factors and mortality in patients with coronary heart disease.

Authors:  Christof Prugger; Jürgen Wellmann; Jan Heidrich; Stefan-Martin Brand-Herrmann; Ulrich Keil
Journal:  Eur J Epidemiol       Date:  2008-10-15       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.